Richard S. A. Tindall

1.7k total citations
29 papers, 1.3k citations indexed

About

Richard S. A. Tindall is a scholar working on Neurology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Richard S. A. Tindall has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Richard S. A. Tindall's work include Peripheral Neuropathies and Disorders (15 papers), Myasthenia Gravis and Thymoma (13 papers) and Parkinson's Disease and Spinal Disorders (4 papers). Richard S. A. Tindall is often cited by papers focused on Peripheral Neuropathies and Disorders (15 papers), Myasthenia Gravis and Thymoma (13 papers) and Parkinson's Disease and Spinal Disorders (4 papers). Richard S. A. Tindall collaborates with scholars based in United States, Australia and United Kingdom. Richard S. A. Tindall's co-authors include L B Wells, J. Theodore Phillips, George Belendiuk, Ralph G. Greenlee, Karen Hall, Pramod K. Mohanty, Urs Scherrer, Barbara J. Morgan, Susanne Vissing and Peter Hanson and has published in prestigious journals such as New England Journal of Medicine, Neurology and Annals of Neurology.

In The Last Decade

Richard S. A. Tindall

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard S. A. Tindall United States 16 752 182 155 147 111 29 1.3k
Jiann‐Horng Yeh Taiwan 18 393 0.5× 402 2.2× 91 0.6× 227 1.5× 23 0.2× 58 1.1k
Anita B. Tryc Germany 19 163 0.2× 137 0.8× 43 0.3× 54 0.4× 108 1.0× 39 983
Yu-Jun Lin Taiwan 19 310 0.4× 223 1.2× 40 0.3× 48 0.3× 60 0.5× 51 1.0k
Yuebing Li United States 16 567 0.8× 108 0.6× 106 0.7× 28 0.2× 129 1.2× 94 905
Michael J. Nash United Kingdom 14 274 0.4× 143 0.8× 23 0.1× 142 1.0× 47 0.4× 38 1.3k
Luca Toti Italy 20 138 0.2× 381 2.1× 54 0.3× 27 0.2× 41 0.4× 62 1.0k
C. Carollo Italy 20 488 0.6× 192 1.1× 123 0.8× 61 0.4× 74 0.7× 55 1.3k
Linda E. Pelinka Austria 18 654 0.9× 225 1.2× 19 0.1× 54 0.4× 25 0.2× 38 1.3k
Urs Fisch Switzerland 17 404 0.5× 192 1.1× 22 0.1× 93 0.6× 54 0.5× 44 766
J. G. McLeod Australia 15 376 0.5× 53 0.3× 15 0.1× 23 0.2× 56 0.5× 26 741

Countries citing papers authored by Richard S. A. Tindall

Since Specialization
Citations

This map shows the geographic impact of Richard S. A. Tindall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. A. Tindall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. A. Tindall more than expected).

Fields of papers citing papers by Richard S. A. Tindall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. A. Tindall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. A. Tindall. The network helps show where Richard S. A. Tindall may publish in the future.

Co-authorship network of co-authors of Richard S. A. Tindall

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. A. Tindall. A scholar is included among the top collaborators of Richard S. A. Tindall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. A. Tindall. Richard S. A. Tindall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tindall, Richard S. A., et al.. (1993). A Clinical Therapeutic Trial of Cyclosporine in Myasthenia Gravisa. Annals of the New York Academy of Sciences. 681(1). 539–551. 189 indexed citations
2.
Tindall, Richard S. A.. (1992). Immunointervention with cyclosporin A in autoimmune neurological disorders. Journal of Autoimmunity. 5. 301–313. 8 indexed citations
3.
Tindall, Richard S. A.. (1991). Therapy of acute and chronic multiple sclerosis.. PubMed. 17(1). 18–25. 1 indexed citations
4.
Tindall, Richard S. A., et al.. (1991). An update on the use of drugs for common eye problems in older patients.. PubMed. 46(11). 51–4, 57. 2 indexed citations
5.
Noort, Stanley van den, Louis R. Caplan, Peter Dyck, et al.. (1990). Assessment [RETIRED]. Neurology. 40(4). 680–680. 50 indexed citations
6.
Scherrer, Urs, Susanne Vissing, Barbara J. Morgan, et al.. (1990). Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart Transplantation. New England Journal of Medicine. 323(11). 693–699. 337 indexed citations
7.
Tindall, Richard S. A.. (1988). A closer look at plasmapheresis in multiple sclerosis: the cons.. PubMed. 38(7 Suppl 2). 53–6. 7 indexed citations
8.
Tindall, Richard S. A.. (1988). Humoral factors in inflammatory disorders of the central and peripheral nervous system. Journal of Neuroimmunology. 20(2-3). 283–296. 2 indexed citations
9.
Bonifacio, Ezio, T.J. Cobain, Roger L. Dawkins, et al.. (1988). Comparison and Standardization of Measurement of Anti-Acetylcholine Receptor Antibody between Laboratories. Autoimmunity. 1(1). 59–66. 3 indexed citations
10.
Tindall, Richard S. A., et al.. (1987). A Double‐Blind Randomized Placebo‐Controlled Trial to Assess the Safety and Efficacy of Cyclosporin A in the Treatment of Myasthenia Gravisa. Annals of the New York Academy of Sciences. 505(1). 854–856. 1 indexed citations
11.
Klein, Harvey G., Peter C. Dau, Max Hamburger, et al.. (1986). Announcement. Journal of Clinical Apheresis. 3(1). i–vi, 1. 18 indexed citations
12.
Tindall, Richard S. A.. (1982). The role of therapeutic apheresis in acute, relapsing, and chronic inflammatory demyelinating polyneuropathy.. PubMed. 106. 205–17. 3 indexed citations
13.
Tindall, Richard S. A., et al.. (1982). Immune regulation in myasthenia gravis: Evidence for an increased suppressor T‐cell population. Annals of Neurology. 12(4). 341–347. 21 indexed citations
14.
Tindall, Richard S. A., et al.. (1982). Plasmapheresis in multiple sclerosis. Neurology. 32(7). 739–739. 42 indexed citations
15.
Zerwekh, Joseph E., Richard W. Homan, Richard S. A. Tindall, & Charles Y.C. Pak. (1982). Decreased serum 24, 25‐dihydroxyvitamin D concentration during long‐term anticonvulsant therapy in adult epileptics. Annals of Neurology. 12(2). 184–186. 15 indexed citations
16.
Feit, Howard, Richard S. A. Tindall, & M. R. Glasberg. (1982). Sources of error in the diagnosis of guillain‐barre syndrome. Muscle & Nerve. 5(2). 111–117. 14 indexed citations
17.
Tindall, Richard S. A.. (1981). Humoral immunity in myasthenia gravis: Biochemical characterization of acquired antireceptor antibodies and clinical correlations. Annals of Neurology. 10(5). 437–447. 68 indexed citations
18.
Tindall, Richard S. A., Matthew Kent, & L B Wells. (1981). A rapid immunoadsorbent radioimmunoassay for anti-acetylcholine receptor antibody. Journal of Immunological Methods. 45(1). 1–14. 15 indexed citations
19.
Tindall, Richard S. A.. (1980). Humoral immunity in myasthenia gravis. Neurology. 30(5). 557–557. 57 indexed citations
20.
Tindall, Richard S. A., et al.. (1978). Serum antibodies to cytomegalovirus in myasthenia gravis. Neurology. 28(3). 273–273. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026